Societies Move Women’s Cardiovascular Risk Earlier in the Clinical Timeline
Four major medical societies have put a more explicit female-specific frame around cardiovascular disease prevention and care, arguing that sex-specific biology and life-stage transitions should no longer sit at the margins of routine risk assessment. The framework, published as three papers in Circulation, comes from the American Heart Association, the American Academy of Pediatrics, the American College of Obstetricians & Gynecologists and the Society for Maternal-Fetal Medicine. Its central message is direct: clinicians need to identify risk earlier, connect specialties more tightly and stop treating heart health as a problem that begins only after symptoms or events appear.
The public health stakes remain stark. Cardiovascular disease, including heart disease and stroke, still causes more deaths in women each year than breast cancer, lung cancer and chronic lung disease combined. It is also the leading cause of medical-related deaths during pregnancy. Yet only 41% of women recognize it as their greatest health threat, a gap that leaves prevention efforts starting too late and too unevenly across care settings.
Progress has stalled in a way that should concern every clinician who sees girls, women and postpartum patients. Only about 60% of U.S. women who experience hypertensive complications during pregnancy receive blood pressure follow-up within six months of delivery. The American Heart Association projects that if current trends continue, the share of women age 20 and older living with high blood pressure will rise from 49% in 2020 to 59% in 2050.
Life-Stage Biology Becomes a Cardiovascular Signal
The newly published Presidential Advisory introduces the Female Life Stage framework, which links distinct biological transitions to cardiovascular risk. Menstrual cycle patterns, pregnancy complications such as preeclampsia and menopause are treated as clinically meaningful markers rather than isolated gynecologic events. The framework also takes a broader view of health by considering cardiovascular, hormonal and emotional factors together, reflecting the reality that risk is shaped by overlapping systems rather than a single organ silo.
This approach has a clear pathophysiologic logic. Pregnancy can function as a physiologic stress test, revealing vascular vulnerability, endothelial dysfunction and hypertensive propensity that may remain hidden in earlier adulthood. Menopause changes the hormonal milieu in ways that can influence vascular tone, lipid patterns and metabolic risk. Abnormal menstrual cycling, especially when persistent, can also flag endocrine and cardiometabolic disruption that deserves attention long before a first chest pain visit or emergency department presentation.
Amanda Marma Perak, M.D., vice-chair of the collaborative writing group and a pediatric cardiologist at Lurie Children’s Hospital in Chicago, said heart health begins long before adulthood. Her point aligns with the framework’s underlying premise: if a girl’s early health history is never documented with cardiovascular consequences in mind, key clues can disappear by the time she reaches reproductive age. A life-course approach gives pediatric, adolescent and adult clinicians a shared map for asking different questions at different stages.
One sentence in the framework carries immediate bedside relevance: menstrual cycle regularity should be assessed ongoingly, not treated as a one-time intake detail.
Screening Moves Across Adolescence, Reproductive Health and Menopause
The Scientific Statement supplies the clinical rationale and turns the life-stage concept into more concrete guidance. It draws from existing guideline recommendations to identify evidence-based, stage-specific steps that can be incorporated into routine practice. Among them are ongoing assessment of menstrual cycle regularity, cardiovascular risk screening at diagnosis of polycystic ovary syndrome, documentation of age at menopause and routine depression and anxiety screening beginning at age 12 and 13, respectively.
The inclusion of mental health screening is not cosmetic. Depression and anxiety can affect sleep, physical activity, medication adherence and care-seeking behavior, all of which can shape cardiovascular trajectories over time. For a patient whose reproductive history also includes hypertensive pregnancy complications or endocrine disorders, these psychosocial factors can intensify risk and complicate follow-up. The framework therefore pushes cardiovascular care closer to the reality of women’s lived clinical histories, where emotional health, hormonal transitions and vascular risk frequently move together.
Sadiya Khan, M.D., chair of the collaborative writing group and professor at the Northwestern University Feinberg School of Medicine, described a practical shift in mindset: instead of waiting until an event occurs, clinicians should take stock of current heart health and the factors that may be influencing it. The logic is preventive, but the operational effect is broader. It asks clinicians across pediatrics, obstetrics, primary care and cardiology to use a shared vocabulary when a patient presents with menstrual irregularity, pregnancy-related hypertension, menopause or another marker that could signal higher long-term risk.
Centers of Excellence Aim to Reduce Fragmentation
The third paper, a Science Advisory, moves beyond screening and diagnosis to the structure of care itself. It proposes a national infrastructure of Comprehensive Centers of Excellence for Women’s Cardiovascular Care, built around interdisciplinary work in clinical care, professional training, research and community engagement. The goal is to reduce fragmentation, identify risk sooner and improve representation of women in clinical research.
These centers would also serve a second purpose: standardize how women’s cardiovascular risk is discussed and acted on across specialties. Khan emphasized the need for a shared playbook and shared language that can be understood by any clinician and any patient. In practical terms, that means a patient seen in obstetrics, pediatrics or primary care should not be forced to start over each time a risk signal appears. The handoff itself becomes part of the intervention.
The proposed national infrastructure is based in part on a survey of clinician leaders at women’s cardiovascular centers or programs, which informed the benefits, challenges and gaps that such centers would need to address. Educational materials are already being developed, including case-based instruction on how to apply the Female Life Stage framework. A network to evaluate and implement changes in care pathways is also being considered, alongside external measures of patient experience such as surveys on how often women feel dismissed by clinicians.
A one-time recommendation will not fix a system that has missed these signals for years.
Funding Gaps, Research Needs and the Cost of Delay
Khan acknowledged that the framework itself does not include capital to build the changes it recommends. The need for funding is not a minor implementation detail; it is the obstacle that determines whether this work stays conceptual or becomes embedded in routine care. Developing centers of excellence and durable clinical models will require collaboration across stakeholders, and the business case rests partly on preventable events being cost-saving when avoided early.
Research capacity remains another constraint. Women remain underrepresented in clinical research, which limits how confidently clinicians can apply population-level evidence to sex-specific risk patterns. The framework is designed to push against that problem by increasing awareness, coordinating care and creating structures that can support better enrollment and better study design. Khan also suggested there may be more national attention on women’s health because of a recent executive order establishing a new division of women’s health at the National Institutes of Health, with the stated aim of increasing scientific review, advancing research and promoting innovation.
The papers were prepared by a volunteer writing group on behalf of the four societies, a detail that reflects both the urgency of the issue and the dependence of this effort on professional consensus rather than dedicated financing. For now, the framework gives clinicians a more explicit way to connect reproductive history, mental health and cardiovascular prevention. The harder question is whether health systems will build the staffing, data capture and referral pathways needed to make that framework visible in everyday care, especially for patients whose first warning sign is still being recognized too late.